HLA-DRB1, major histocompatibility complex, class II, DR beta 1, 3123
N. diseases: 68; N. variants: 172
Source: CURATED ×
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.742 | 0.400 | 6 | 32602623 | intergenic variant | T/C | snv | 0.27 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 4 | 2007 | 2011 | |||||||
|
0.752 | 0.360 | 6 | 32609603 | intergenic variant | A/G | snv | 0.19 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.810 | 1.000 | 3 | 2007 | 2018 | |||||||
|
0.851 | 0.240 | 6 | 32606394 | intergenic variant | G/A;C | snv |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.800 | 1.000 | 2 | 2007 | 2011 | ||||||||
|
0.925 | 0.160 | 6 | 32598244 | intergenic variant | T/G | snv | 0.42 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.790 | 0.400 | 6 | 32601914 | intergenic variant | G/A | snv | 0.27 |
|
Skin and Connective Tissue Diseases; Immune System Diseases; Nervous System Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.120 | 6 | 32608701 | regulatory region variant | T/A;C | snv |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.800 | 1.000 | 2 | 2009 | 2013 | ||||||||
|
0.742 | 0.400 | 6 | 32602623 | intergenic variant | T/C | snv | 0.27 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.752 | 0.360 | 6 | 32609603 | intergenic variant | A/G | snv | 0.19 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.752 | 0.360 | 6 | 32609603 | intergenic variant | A/G | snv | 0.19 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 0.080 | 6 | 32606214 | intergenic variant | T/A;G | snv |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.800 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
1.000 | 0.080 | 6 | 32607592 | intergenic variant | G/T | snv | 0.84 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.882 | 0.120 | 6 | 32610275 | intergenic variant | G/A | snv | 0.43 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 2 | 2010 | 2012 | |||||||
|
0.742 | 0.400 | 6 | 32602623 | intergenic variant | T/C | snv | 0.27 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.851 | 0.280 | 6 | 32604474 | intergenic variant | T/A;C | snv |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
1.000 | 0.080 | 6 | 32578889 | 3 prime UTR variant | G/A;C;T | snv | 2.6E-02 | 2.1E-02 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||
|
1.000 | 0.080 | 6 | 32586302 | intron variant | T/C | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
1.000 | 0.080 | 6 | 32607091 | intergenic variant | C/T | snv | 0.14 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
6 | 32606581 | intergenic variant | G/A | snv | 0.20 |
|
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
0.742 | 0.400 | 6 | 32602623 | intergenic variant | T/C | snv | 0.27 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.851 | 0.280 | 6 | 32604474 | intergenic variant | T/A;C | snv |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2007 | 2007 | ||||||||
|
0.790 | 0.400 | 6 | 32601914 | intergenic variant | G/A | snv | 0.27 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2007 | 2007 | |||||||
|
1.000 | 0.120 | 6 | 32605638 | intergenic variant | A/G | snv | 0.13 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.752 | 0.360 | 6 | 32609603 | intergenic variant | A/G | snv | 0.19 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.851 | 0.240 | 6 | 32606394 | intergenic variant | G/A;C | snv |
|
Nervous System Diseases; Mental Disorders | 0.700 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
1.000 | 0.080 | 6 | 32582545 | intron variant | A/C;T | snv |
|
Nervous System Diseases; Mental Disorders | 0.700 | 1.000 | 1 | 2019 | 2019 |